These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma. Christensen TT; Frystyk J; Poulsen PL Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043 [TBL] [Abstract][Full Text] [Related]
4. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752 [TBL] [Abstract][Full Text] [Related]
5. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Sawka AM; Jaeschke R; Singh RJ; Young WF J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179 [TBL] [Abstract][Full Text] [Related]
6. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma. Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804 [TBL] [Abstract][Full Text] [Related]
8. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients. Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review. Därr R; Kuhn M; Bode C; Bornstein SR; Pacak K; Lenders JWM; Eisenhofer G Endocrine; 2017 Jun; 56(3):495-503. PubMed ID: 28405881 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas. Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581 [TBL] [Abstract][Full Text] [Related]
14. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098 [TBL] [Abstract][Full Text] [Related]
15. Plasma metanephrines in the diagnosis of pheochromocytoma. Lenders JW; Keiser HR; Goldstein DS; Willemsen JJ; Friberg P; Jacobs MC; Kloppenborg PW; Thien T; Eisenhofer G Ann Intern Med; 1995 Jul; 123(2):101-9. PubMed ID: 7778821 [TBL] [Abstract][Full Text] [Related]
16. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option? Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575 [TBL] [Abstract][Full Text] [Related]
17. Case report of a phantom pheochromocytoma. Joyce CM; Melvin A; O'Shea PM; Costelloe SJ; O'Halloran DJ Biochem Med (Zagreb); 2020 Jun; 30(2):021003. PubMed ID: 32550819 [TBL] [Abstract][Full Text] [Related]
18. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias. Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255 [TBL] [Abstract][Full Text] [Related]
19. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498 [TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases. Kawashima A; Sone M; Inagaki N; Okamoto K; Tsuiki M; Izawa S; Otsuki M; Okamura S; Ichijo T; Katabami T; Takeda Y; Yoshimoto T; Naruse M; Tanabe A Endocrine; 2021 Oct; 74(1):155-162. PubMed ID: 34272648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]